[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Androgen Deprivation Therapy (ADT) Market Research Report 2016

September 2016 | 128 pages | ID: G178791929BEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Androgen Deprivation Therapy (ADT)

Revenue, means the sales value of Androgen Deprivation Therapy (ADT)

This report studies Androgen Deprivation Therapy (ADT) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Pfizer Inc. (USA)
  • Abbott Laboratories (USA)
  • Genentech Inc. (USA)
  • GlaxoSmithKline Plc (UK)
  • Immunomedics, Inc. (USA)
  • Indevus Pharmaceuticals Inc. (USA)
  • Novartis AG (Switzerland)
  • OSI Pharmaceuticals, Inc. (USA)
  • Paladin Labs Inc. (Canada)
  • ALZA Corporation (USA)
  • Amgen Inc. (USA)
  • AstraZeneca PLC (UK)
  • Medimmune, LLC (USA)
  • Bristol-Myers Squibb Company (USA)
  • Cell Genesys Inc. (USA)
  • Dendreon Corporation (USA)
  • EUSA Pharma, (USA) Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Progenics Pharmaceuticals, Inc. (USA)
  • Sanofi-Aventis SA (France)
  • Spectrum Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Company Limited (Japan)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Androgen Deprivation Therapy (ADT) in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Androgen Deprivation Therapy (ADT) in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Androgen Deprivation Therapy (ADT) Market Research Report 2016

1 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET OVERVIEW

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Androgen Deprivation Therapy (ADT) Segment by Type
  1.2.1 Global Production Market Share of Androgen Deprivation Therapy (ADT) by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Androgen Deprivation Therapy (ADT) Segment by Application
  1.3.1 Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Androgen Deprivation Therapy (ADT) Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Androgen Deprivation Therapy (ADT) (2011-2021)

2 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET COMPETITION BY MANUFACTURERS

2.1 Global Androgen Deprivation Therapy (ADT) Production and Share by Manufacturers (2015 and 2016)
2.2 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Androgen Deprivation Therapy (ADT) Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Androgen Deprivation Therapy (ADT) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Androgen Deprivation Therapy (ADT) Market Competitive Situation and Trends
  2.5.1 Androgen Deprivation Therapy (ADT) Market Concentration Rate
  2.5.2 Androgen Deprivation Therapy (ADT) Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Androgen Deprivation Therapy (ADT) Production and Market Share by Region (2011-2016)
3.2 Global Androgen Deprivation Therapy (ADT) Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Androgen Deprivation Therapy (ADT) Consumption by Regions (2011-2016)
4.2 North America Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Androgen Deprivation Therapy (ADT) Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Androgen Deprivation Therapy (ADT) Production and Market Share by Type (2011-2016)
5.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2011-2016)
5.3 Global Androgen Deprivation Therapy (ADT) Price by Type (2011-2016)
5.4 Global Androgen Deprivation Therapy (ADT) Production Growth by Type (2011-2016)

6 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET ANALYSIS BY APPLICATION

6.1 Global Androgen Deprivation Therapy (ADT) Consumption and Market Share by Application (2011-2016)
6.2 Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer Inc. (USA)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Genentech Inc. (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline Plc (UK)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Immunomedics, Inc. (USA)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novartis AG (Switzerland)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Paladin Labs Inc. (Canada)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 ALZA Corporation (USA)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Amgen Inc. (USA)
7.12 AstraZeneca PLC (UK)
7.13 Medimmune, LLC (USA)
7.14 Bristol-Myers Squibb Company (USA)
7.15 Cell Genesys Inc. (USA)
7.16 Dendreon Corporation (USA)
7.17 EUSA Pharma, (USA) Inc. (USA)
7.18 F. Hoffmann-La Roche Ltd. (Switzerland)
7.19 Progenics Pharmaceuticals, Inc. (USA)
7.20 Sanofi-Aventis SA (France)
7.21 Spectrum Pharmaceuticals, Inc. (USA)
7.22 Takeda Pharmaceutical Company Limited (Japan)

8 ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURING COST ANALYSIS

8.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST (2016-2021)

12.1 Global Androgen Deprivation Therapy (ADT) Production, Revenue Forecast (2016-2021)
12.2 Global Androgen Deprivation Therapy (ADT) Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Androgen Deprivation Therapy (ADT) Production Forecast by Type (2016-2021)
12.4 Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2016-2021)
12.5 Androgen Deprivation Therapy (ADT) Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Androgen Deprivation Therapy (ADT)
Figure Global Production Market Share of Androgen Deprivation Therapy (ADT) by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Androgen Deprivation Therapy (ADT) Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Androgen Deprivation Therapy (ADT) Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Androgen Deprivation Therapy (ADT) Production of Key Manufacturers (2015 and 2016)
Table Global Androgen Deprivation Therapy (ADT) Production Share by Manufacturers (2015 and 2016)
Figure 2015 Androgen Deprivation Therapy (ADT) Production Share by Manufacturers
Figure 2016 Androgen Deprivation Therapy (ADT) Production Share by Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table 2016 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table Global Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers in 2015
Table Manufacturers Androgen Deprivation Therapy (ADT) Manufacturing Base Distribution and Sales Area
Table Manufacturers Androgen Deprivation Therapy (ADT) Product Type
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 3 Manufacturers
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 5 Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Production by Regions (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Production and Market Share by Regions (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Production Market Share by Regions (2011-2016)
Figure 2015 Global Androgen Deprivation Therapy (ADT) Production Market Share by Regions
Table Global Androgen Deprivation Therapy (ADT) Revenue by Regions (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Regions (2011-2016)
Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Regions
Table Global Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table China Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table India Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market by Regions (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Regions
Table North America Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table Europe Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table China Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table Japan Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table India Androgen Deprivation Therapy (ADT) Production, Consumption, Import & Export (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Production by Type (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Production Share by Type (2011-2016)
Figure Production Market Share of Androgen Deprivation Therapy (ADT) by Type (2011-2016)
Figure 2015 Production Market Share of Androgen Deprivation Therapy (ADT) by Type
Table Global Androgen Deprivation Therapy (ADT) Revenue by Type (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Androgen Deprivation Therapy (ADT) by Type (2011-2016)
Figure 2015 Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type
Table Global Androgen Deprivation Therapy (ADT) Price by Type (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Production Growth by Type (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Consumption by Application (2011-2016)
Table Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Application (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Market Share by Application in 2015
Table Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2011-2016)
Figure Global Androgen Deprivation Therapy (ADT) Consumption Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Production, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)
Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015
Table Major Buyers of Androgen Deprivation Therapy (ADT)
Table Distributors/Traders List
Figure Global Androgen Deprivation Therapy (ADT) Production and Growth Rate Forecast (2016-2021)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2016-2021)
Table Global Androgen Deprivation Therapy (ADT) Production Forecast by Regions (2016-2021)
Table Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Regions (2016-2021)
Table Global Androgen Deprivation Therapy (ADT) Production Forecast by Type (2016-2021)
Table Global Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories